Results 71 to 80 of about 165,269 (210)

TREM2-dependent effects on microglia in Alzheimer\u27s Disease [PDF]

open access: yes, 2018
Alzheimer’s disease (AD) is a late-onset dementia characterized by the deposition of amyloid plaques and formation of neurofibrillary tangles (NFTs) which lead to neuronal loss and cognitive deficits.
Colonna, Marco   +2 more
core   +3 more sources

Mammalian target of rapamycin inhibition in hepatocellular carcinoma

open access: yesWorld Journal of Hepatology, 2014
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. It is associated with a poor prognosis and has limited treatment options. Sorafenib, a multi-targeted kinase inhibitor, is the only available systemic agent for treatment of HCC that improves overall survival for patients with advanced stage disease ...
René E, Ashworth, Jennifer, Wu
openaire   +2 more sources

Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways

open access: yesBMC Cancer, 2017
Background Mesothelioma is resistant to conventional treatments and is often defective in p53 pathways. We then examined anti-tumor effects of metformin, an agent for type 2 diabetes, and combinatory effects of metformin and nutlin-3a, an inhibitor for ...
Kengo Shimazu   +9 more
doaj   +1 more source

The role of RICTOR downstream of receptor tyrosine kinase in cancers

open access: yesMolecular Cancer, 2018
The importance of the network defined by phosphatidylinositol-3-kinase (PI3K), AKT and mammalian target of rapamycin (mTOR) downstream of Receptor Tyrosine Kinase (RTK) has been known for many years but the central role of RICTOR (rapamycin-insensitive ...
Ahlem Jebali, Nicolas Dumaz
doaj   +1 more source

Az mTOR (mammalian target of rapamycin) aktivitás jelentősége humán lymphomákban [PDF]

open access: yes, 2014
Neoplastic processes, tumor growth, and tumor cell proliferation and survival are often due to the altered activation of different signaling pathways. The increased activity of PI3K/AKT/mTOR signaling has been shown to be an important regulator of tumor ...
Márk, Ágnes
core   +2 more sources

Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia–Reperfusion With Increased Blood–Brain Barrier Disruption

open access: yesFrontiers in Physiology, 2021
Daniel J. Beard   +4 more
doaj   +1 more source

Longer recurrence‐free survival in a patient with metastatic renal cell carcinoma treated with temsirolimus

open access: yesClinical Case Reports, 2017
Key Clinical Message Temsirolimus did not demonstrate an efficacy advantage compared with sorafenib as second‐line therapy in patients with metastatic renal cell carcinoma (mRCC).
Tendo Satoh   +5 more
doaj   +1 more source

A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus [PDF]

open access: yes, 2002
Many forms of long-lasting behavioral and synaptic plasticity require the synthesis of new proteins. For example, long-term potentiation (LTIP) that endures for more than an hour requires both transcription and translation.
Gingras, Anne-Claude   +5 more
core  

Deletion of Tsc2 in nociceptors reduces target innervation, ion channel expression, and sensitivity to heat [PDF]

open access: yes, 2018
The mechanistic target of rapamycin complex 1 (mTORC1) is known to regulate cellular growth pathways, and its genetic activation is sufficient to enhance regenerative axon growth following injury to the central or peripheral nervous systems.
Carlin, Dan   +6 more
core   +2 more sources

mTORC2 Deficiency Alters the Metabolic Profile of Conventional Dendritic Cells

open access: yesFrontiers in Immunology, 2019
In myeloid dendritic cells (DC), deletion of the mechanistic target of rapamycin complex 2 (TORC2) results in an augmented pro-inflammatory phenotype and T cell stimulatory activity; however, the underlying mechanism has not been resolved.
Alicia R. Watson   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy